Vitamin K antagonists with or without long‐term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events

BACKGROUND: It remains uncertain whether patients with atrial fibrillation (AF) requiring long‐term oral anticoagulation (OAC) and with stable coronary artery disease (CAD) should receive antiplatelet therapy (APT) in addition to OAC. HYPOTHESIS: APT in addition to OAC would be more effective than O...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cardiol
Glavni autori: Lemesle, Gilles, Ducrocq, Gregory, Elbez, Yedid, Van Belle, Eric, Goto, Shinya, Cannon, Christopher P., Bauters, Christophe, Bhatt, Deepak L., Steg, Philippe Gabriel
Format: Artigo
Jezik:Inglês
Izdano: Wiley Periodicals, Inc. 2017
Teme:
Clinical Investigations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490437/
https://ncbi.nlm.nih.gov/pubmed/28692742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22750
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items